Editorial (Public Health Pharmacogenomics and the Design Principles for Global Public Goods – Moving Genomics to Responsible Innovation)

Vural      Ozdemir; Alexander      Borda-Rodriguez; Edward      S. Dove; Lynnette      R. Ferguson; Farah      Huzair; Vangelis      G. Manolopoulos; Mario      Masellis; Djims      Milius; Louise      Warnich; Sanjeeva      Srivastava

doi:10.2174/1875692111311010001

Keywords: Genomics and development, genomics without borders, global governance of biotechnology innovation and uncertainty, P5 medicine, public health pharmacogenomics, responsible innovation, STS and organizations, theranostic medicine

Rights & Permissions Print Cite

Current Pharmacogenomics and Personalized Medicine

Title:Editorial (Public Health Pharmacogenomics and the Design Principles for Global Public Goods – Moving Genomics to Responsible Innovation)

Volume: 11 Issue: 1

Author(s): Vural Ozdemir, Alexander Borda-Rodriguez, Edward S. Dove, Lynnette R. Ferguson, Farah Huzair, Vangelis G. Manolopoulos, Mario Masellis, Djims Milius, Louise Warnich and Sanjeeva Srivastava

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Ozdemir Vural, Borda-Rodriguez Alexander, S. Dove Edward, R. Ferguson Lynnette, Huzair Farah, G. Manolopoulos Vangelis, Masellis Mario, Milius Djims, Warnich Louise and Srivastava Sanjeeva, Editorial (Public Health Pharmacogenomics and the Design Principles for Global Public Goods – Moving Genomics to Responsible Innovation), Current Pharmacogenomics and Personalized Medicine 2013; 11 (1) . https://dx.doi.org/10.2174/1875692111311010001